Al-Mukhtar, S., Aladul, M., Younus, M., Salih, D. (2024). Simplification of Patient-Reported Outcome Measures in Oncology: A Narrative Review. , 21(3), 117-127. doi: 10.33899/iraqij.p.2024.148130.1091
Shahad Abdul Salam Al-Mukhtar; Mohammed Ibrahim Aladul; Manal Mohammed Younus; Dian J. Salih. "Simplification of Patient-Reported Outcome Measures in Oncology: A Narrative Review". , 21, 3, 2024, 117-127. doi: 10.33899/iraqij.p.2024.148130.1091
Al-Mukhtar, S., Aladul, M., Younus, M., Salih, D. (2024). 'Simplification of Patient-Reported Outcome Measures in Oncology: A Narrative Review', , 21(3), pp. 117-127. doi: 10.33899/iraqij.p.2024.148130.1091
Al-Mukhtar, S., Aladul, M., Younus, M., Salih, D. Simplification of Patient-Reported Outcome Measures in Oncology: A Narrative Review. , 2024; 21(3): 117-127. doi: 10.33899/iraqij.p.2024.148130.1091

Simplification of Patient-Reported Outcome Measures in Oncology: A Narrative Review

Iraqi Journal of Pharmacy
Volume 21, Issue 3, September 2024, Pages 117-127    PDF (668.3 K)
Document Type: Review Paper
DOI: 10.33899/iraqij.p.2024.148130.1091
Authors
Shahad Abdul Salam Al-Mukhtar1; Mohammed Ibrahim Aladul* 1; Manal Mohammed Younus2; Dian J. Salih3
1Department of Clinical Pharmacy, College of Pharmacy, University of Mosul, Mosul, Iraq
2Iraqi Pharmacovigilance Center, Ministry of Health, Baghdad, Iraq
3Department of Surgical and Clinical Medicine, University of Foggia, Foggia, Italy
Abstract
Background: Patient-reported outcomes (PROs) are reports provided by patients themselves detailing their medical health state or behavior related to an illness or medication use, without any interpretation by healthcare professionals. PROs are used to evaluate health status that cannot be quantified through tangible measures, for primary outcomes such as pain severity, and secondary outcomes such as quality of life. Patient-reported outcome measures (PROMs) are instruments or methods developed by professionals to assess data on PROs directly provided by patients during reporting procedures. In the oncology field, they are important to determine the impact of cancer and chemotherapy on patient's physical symptoms, mental well-being, and social functioning. The health system turned towards using PROMs as tools for remote monitoring, conducting visits when needed, and alerting stakeholders at the right time. Aim: To describe the uses and types of PROMs in use in clinical practice and the simplified PROMs that have been developed in oncology. Conclusion: PROMs are widely used in oncology for data collection. It became necessary to simplify measures by using patients' language, downsizing content, and promoting electronic PROMs through technological programs.

Highlights
  • Generic and specific PROMs play a crucial role in the oncology field.
  • PROMs should be validated and translated into the native language.
  • Several factors contribute to simplifying available PROMs.
  • The current trend is shifting from using pen and paper PROMs to electronic PROMs.
Keywords
Adverse reaction; Oncology; Patient-reported Outcomes
References
  1. Weldring T, Smith SM. Patient-reported outcomes (pros) and patient-reported outcome measures (PROMs). Health services insights 2013;6:HSI-S11093.
  2. Nguyen H, Butow P, Dhillon H, Sundaresan P. A review of the barriers to using patient‐reported outcomes (PROs) and patient‐reported outcome measures (PROMs) in routine cancer care. Journal of medical radiation sciences 2021;68(2):186-95.
  3. Snyder CF, Jensen RE, Segal JB, Wu AW. Patient-reported outcomes (PROs): putting the patient perspective in patient-centered outcomes research. Medical care 2013;1;51:S73-S79.
  4. Ip EH. Editorial to the invited special section “advancing methods to assess patient-reported outcomes: Lessons learned from the patient-reported outcomes measurement information system®(PROMIS®) initiative”. Psychometrika 2021;86(3):669-6670.
  5. Slade AL, Retzer A, Ahmed K, Kyte D, Keeley T, Armes J, Brown JM, Calman L, Gavin A, Glaser AW, Greenfield DM. Systematic review of the use of translated patient-reported outcome measures in cancer trials. Trials 2021;22:1-6.
  6. Shabila NP, Al-Tawil NG, Al-Hadithi T, Sondorp E. Assessment of the Iraqi primary care referral system: reporting a high self-requested referral rate. Middle East J Fam Med 2012;1;10(3):4-10.
  7. Bevans M, Ross A, Cella D. Patient-Reported Outcomes Measurement Information System (PROMIS): efficient, standardized tools to measure self-reported health and quality of life. Nursing outlook 2014;1;62(5):339-45.
  8. Kim A, Chung KC, Keir C, Patrick DL. Patient-reported outcomes associated with cancer screening: a systematic review. BMC cancer 2022;1;22(1):223.
  9. Churruca K, Pomare C, Ellis LA, Long JC, Henderson SB, Murphy LE, Leahy CJ, Braithwaite J. Patient‐reported outcome measures (PROMs): a review of generic and condition‐specific measures and a discussion of trends and issues. Health Expectations. 2021;24(4):1015-24.
  10. Müller-Bühl U, Engeser P, Klimm HD, Wiesemann A. Quality of life and objective disease criteria in patients with intermittent claudication in general practice. Family practice. 2003;1;20(1):36-40.
  11. Wu AW, Kharrazi H, Boulware LE, Snyder CF. Measure once, cut twice—adding patient-reported outcome measures to the electronic health record for comparative effectiveness research. Journal of clinical epidemiology 2013;1;66(8):S12-20.
  12. Vodicka E, Kim K, Devine EB, Gnanasakthy A, Scoggins JF, Patrick DL. Inclusion of patient-reported outcome measures in registered clinical trials: evidence from ClinicalTrials. gov (2007–2013). Contemporary clinical trials 2015;1;43:1-9.
  13. Bottomley A, Jones D, Claassens L. Patient-reported outcomes: assessment and current perspectives of the guidelines of the Food and Drug Administration and the reflection paper of the European Medicines Agency. European journal of cancer 2009;1;45(3):347-53.
  14. Cella D, Hahn EA, Jensen SE, Butt Z, Nowinski CJ, Rothrock N, Lohr KN. Patient-reported outcomes in performance measurement.USA;2015.
  15. Lipscomb J, Gotay CC, Snyder CF. Patient‐reported outcomes in cancer: a review of recent research and policy initiatives. CA: A Cancer Journal for Clinicians. 2007;57(5):278-300.
  16. S. Department of Health and Human Services FDA Center for Drug Evaluation and Research, U.S. Department of Health and Human Services FDA Center for Biologics Evaluation and Research, and U.S. Department of Health and Human Services FDA Center for Devices and Radiological Health. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes. 2006;4:79.
  17. Williams K, Sansoni J, Darcy M, Grootemaat P, Thompson C. Patient-reported outcome measures. Literature review. Sydney: Australian Commission on Safety and Quality in Health Care. 2016.
  18. Oude Voshaar M, Terwee CB, Haverman L, van der Kolk B, Harkes M, van Woerden CS, van Breda F, Breukink S, de Hoop I, Vermeulen H, de Graaf E. Development of a standard set of PROs and generic PROMs for Dutch medical specialist care: Recommendations from the Outcome-Based Healthcare Program Working Group Generic PROMs. Quality of life research. 2023;32(6):1595-605.
  19. Voon PJ, Cella D, Hansen AR. Health‐related quality‐of‐life assessment of patients with solid tumors on immuno‐oncology therapies. Cancer 2021;127(9):1360-8.
  20. Dincer AN, Brunckhorst O, Genel O, Dasgupta P, Muneer A, Ahmed K. Quality of life, anxiety and depression patient‐reported outcome measures in testicular cancer: A systematic review. Psycho‐Oncology 2021;30(9):1420-9.
  21. Rabin R, Charro FD. EQ-SD: a measure of health status from the EuroQol Group. Annals of medicine 2001;33(5):337-43.
  22. Black N. Patient reported outcome measures could help transform healthcare. The British Medical Journal 2013;346.
  23. Ware Jr JE, Sherbourne CD. The MOS 36-ltem short-form health survey (SF-36): I. Conceptual framework and item selection. Medical care 1992;30(6):473-83.
  24. Stewart AL, Hays RD, Ware Jr JE. The MOS short-form general health survey: reliability and validity in a patient population. Medical care 1988;26(7):724-735.
  25. Winkelmann C, Mezentseva A, Vogt B, Neumann T. Patient-Reported Outcome Measures in Liver and Gastrointestinal Cancer Randomized Controlled Trials. International Journal of Environmental Research and Public Health 2023;20(13):6293.
  26. Boyes H, Barraclough J, Ratansi R, Rogers SN, Kanatas A. Structured review of the patient-reported outcome instruments used in clinical trials in head and neck surgery. British Journal of Oral and Maxillofacial Surgery 2018;56(3):161-7.
  27. Arraras JI, Arias F, Tejedor M, Pruja E, Marcos M, Martínez E, Valerdi J. The EORTC QLQ‐C30 (version 3.0) quality of life questionnaire: validation study for Spain with head and neck cancer patients. Psycho‐Oncology: Journal of the Psychological, Social and Behavioral Dimensions of Cancer 2002;11(3):249-56.
  28. Besson A, Deftereos I, Chan S, Faragher IG, Kinsella R, Yeung JM. Understanding patient-reported outcome measures in colorectal cancer. Future Oncology 2019;15(10):1135-46.
  29. Schurr T, Loth F, Lidington E, Piccinin C, Arraras JI, Groenvold M, Holzner B, van Leeuwen M, Petersen MA, Schmidt H, Young T. Patient-reported outcome measures for physical function in cancer patients: content comparison of the EORTC CAT Core, EORTC QLQ-C30, SF-36, FACT-G, and PROMIS measures using the International Classification of Functioning, Disability and Health. BMC medical research methodology 2023;21;23(1):21.
  30. Sansoni JE. Health outcomes: an overview from an Australian perspective.2016.
  31. Mpundu-Kaambwa C, Bulamu NB, Lines L, Chen G, Whitehurst DG, Dalziel K, Devlin N, Ratcliffe J. Exploring the Use of Pictorial Approaches in the Development of Paediatric Patient-Reported Outcome Instruments: A Systematic Review. PharmacoEconomics 2024;1-29.
  32. Manificat S, Dazord A, Cochat P, Morin D, Plainguet F, Debray D. Quality of life of children and adolescents after kidney or liver transplantation: child, parents and caregiver's point of view. Pediatric transplantation 2003;7(3):228-35.
  33. Janssens A, Coon JT, Rogers M, Allen K, Green C, Jenkinson C, Tennant A, Logan S, Morris C. A systematic review of generic multidimensional patient-reported outcome measures for children, part I: descriptive characteristics. Value in Health 2015;18(2):315-33.
  34. Beck AT, Guth D, Steer RA, Ball R. Screening for major depression disorders in medical inpatients with the Beck Depression Inventory for Primary Care. Behaviour research and therapy 1997;35(8):785-91.
  35. Al Sayah F, Jin X, Johnson JA. Selection of patient-reported outcome measures (PROMs) for use in health systems. Journal of patient-reported outcomes 2021;5:1-5.
  36. Shearer D, Morshed S. Common generic measures of health related quality of life in injured patients. Injury 2011;42(3):241-7.
  37. Cella D, Nowinski CJ. Measuring quality of life in chronic illness: the functional assessment of chronic illness therapy measurement system. Archives of physical medicine and rehabilitation 2002;83:S10-7.
  38. Owolabi MO. Which is more valid for stroke patients: generic or stroke-specific quality of life measures?. Neuroepidemiology 2010;34(1):8-12.
  39. Comins JD, Brodersen J, Siersma V, Jensen J, Hansen CF, Krogsgaard MR. How to develop a condition‐specific PROM. Scandinavian Journal of Medicine & Science in Sports 2021;31(6):1216-24.
  40. Graupner C, Kimman ML, Mul S, Slok AH, Claessens D, Kleijnen J, Dirksen CD, Breukink SO. Patient outcomes, patient experiences and process indicators associated with the routine use of patient-reported outcome measures (PROMs) in cancer care: a systematic review. Supportive Care in Cancer 2021;29:573-93.
  41. Graupner C, Breukink SO, Mul S, Claessens D, Slok AH, Kimman ML. Patient-reported outcome measures in oncology: a qualitative study of the healthcare professional’s perspective. Supportive Care in Cancer 2021;29:5253-61.
  42. Boyes A, Newell S, Girgis A, McElduff P, Sanson‐Fisher R. Does routine assessment and real‐time feedback improve cancer patients’ psychosocial well‐being?. European journal of cancer care 2006;15(2):163-71
  43. van Egdom LS, Oemrawsingh A, Verweij LM, Lingsma HF, Koppert LB, Verhoef C, Klazinga NS, Hazelzet JA. Implementing patient-reported outcome measures in clinical breast cancer care: a systematic review. Value in Health 2019;1;22(10):1197-226.
  44. Kotronoulas G, Kearney N, Maguire R, Harrow A, Di Domenico D, Croy S, MacGillivray S. What is the value of the routine use of patient-reported outcome measures toward improvement of patient outcomes, processes of care, and health service outcomes in cancer care? A systematic review of controlled trials. Journal of clinical oncology 2014;32(14):1480-510.
  45. Howell D, Molloy S, Wilkinson K, Green E, Orchard K, Wang K, Liberty J. Patient-reported outcomes in routine cancer clinical practice: a scoping review of use, impact on health outcomes, and implementation factors. Annals of Oncology 2015;26(9):1846-58.
  46. Govindaraj R, Agar M, Currow D, Luckett T. Assessing Patient-Reported Outcomes in Routine Cancer Clinical Care Using Electronic Administration and Telehealth Technologies: Realist Synthesis of Potential Mechanisms for Improving Health Outcomes. Journal of medical Internet research 2023;25:e48483.
  47. Denis F, Lethrosne C, Pourel N, Molinier O, Pointreau Y, Domont J, Bourgeois H, Senellart H, Trémolières P, Lizée T, Bennouna J. Randomized trial comparing a web-mediated follow-up with routine surveillance in lung cancer patients. JNCI: Journal of the National Cancer Institute 2017;109(9):djx029.
  48. Basch E, Schrag D, Henson S, Jansen J, Ginos B, Stover AM, Carr P, Spears PA, Jonsson M, Deal AM, Bennett AV. Effect of electronic symptom monitoring on patient-reported outcomes among patients with metastatic cancer: a randomized clinical trial. Jama 2022;327(24):2413-22.
  49. Murphy M, Hollinghurst S, Salisbury C. Identification, description and appraisal of generic PROMs for primary care: a systematic review. BMC family practice 2018;19:1-2
  50. Herdman M, Gudex C, Lloyd A, Janssen MF, Kind P, Parkin D, Bonsel G, Badia X. Development and preliminary testing of the new five-level version of EQ-5D (EQ-5D-5L). Quality of life research 2011;20:1727-36.
  51. Balestroni G, Bertolotti G. EuroQol-5D (EQ-5D): an instrument for measuring quality of life. Monaldi Archives for Chest Disease 2012;78(3).
  52. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Medical care 1996;34(3):220-33.
  53. Cleeland CS, Mendoza TR, Wang XS, Chou C, Harle MT, Morrissey M, Engstrom MC. Assessing symptom distress in cancer patients: the MD Anderson Symptom Inventory. Cancer: Interdisciplinary International Journal of the American Cancer Society 2000;89(7):1634-46.
  54. Ravens-Sieberer U, Gosch A, Rajmil L, Erhart M, Bruil J, Duer W, Auquier P, Power M, Abel T, Czemy L, Mazur J. KIDSCREEN-52 quality-of-life measure for children and adolescents. Expert review of pharmacoeconomics & outcomes research. 2005;5(3):353-64.
  55. Weingärtner V, Dargatz N, Weber C, Mueller D, Stock S, Voltz R, Gaertner J. Patient reported outcomes in randomized controlled cancer trials in advanced disease: a structured literature review. Expert review of clinical pharmacology 2016;9(6):821-9.
  56. Bergman B, Aaronson NK, Ahmedzai S, Kaasa S, Sullivan M. The EORTC QLQ-LC13: a modular supplement to the EORTC core quality of life questionnaire (QLQ-C30) for use in lung cancer clinical trials. European journal of cancer 1994;30(5):635-42.
  57. Preston NJ, Wilson N, Wood NJ, Brine J, Ferreira J, Brearley SG. Patient‐reported outcome measures for use in gynaecological oncology: A systematic review. British Journal of Obstetrics and Gynaecology: An International Journal of Obstetrics & Gynaecology 2015;122(5):615-22.
  58. van Rooij JA, Roubos J, Vrancken Peeters NJ, Rijken BF, Corten EM, Mureau MA. Long‐term patient‐reported outcomes after reconstructive surgery for head and neck cancer: A systematic review. Head & Neck 2023;45(9):2469-77.
  59. Singer S, Arraras JI, Chie WC, Fisher SE, Galalae R, Hammerlid E, Nicolatou-Galitis O, Schmalz C, Verdonck-de Leeuw I, Gamper E, Keszte J. Performance of the EORTC questionnaire for the assessment of quality of life in head and neck cancer patients EORTC QLQ-H&N35: a methodological review. Quality of Life Research 2013;22:1927-41.
  60. Tennant A, Penta M, Tesio L, Grimby G, Thonnard JL, Slade A, Lawton G, Simone A, Carter J, Lundgren-Nilsson Å, Tripolski M. Assessing and adjusting for cross-cultural validity of impairment and activity limitation scales through differential item functioning within the framework of the Rasch model: the PRO-ESOR project. Medical care 2004;42(1):I-37.
  61. Patrick DL, Burke LB, Gwaltney CJ, Leidy NK, Martin ML, Molsen E, Ring L. Content validity—establishing and reporting the evidence in newly developed patient-reported outcomes (PRO) instruments for medical product evaluation: ISPOR PRO Good Research Practices Task Force report: part 2—assessing respondent understanding. Value in Health 2011;14(8):978-88.
  62. Lord FM, Novick MR. Statistical theories of mental test scores. IAP; 2008.
  63. Wright BD. A history of social science measurement. Educational measurement: Issues and practice. 1997;16(4):33-45.
  64. Krogsgaard MR, Brodersen J, Christensen KB, Siersma V, Kreiner S, Jensen J, Hansen CF, Comins JD. What is a PROM and why do we need it?. Scandinavian journal of medicine & science in sports 2021;31(5):967-71.
  65. Dobrozsi, S., & Panepinto, J. (2015). Patient-reported outcomes in clinical practice. Hematology 2014, the American Society of Hematology Education Program Book, 2015(1), 501-506.‏
  66. for Drug HS, for Biologics HS, for Devices HS, Health R. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance. Health and Quality of Life Outcomes 2006;4:79.
  67. Andersen Jr MJ, Yvellez OV, El Jurdi K, Lei D, Pearl TA, Zmeter N, Rubin DT. Simplification of Validated Patient-Reported Outcome Instruments in Inflammatory Bowel Disease: 629. Official journal of the American College of Gastroenterology| ACG. 2018 Oct 1;113:S357.
  68. Nguyen H, Butow P, Dhillon H, Morris L, Brown A, West K, Sundaresan P. Using patient‐reported outcomes (PROs) and patient‐reported outcome measures (PROMs) in routine head and neck cancer care: What do health professionals perceive as barriers and facilitators?. Journal of Medical Imaging and Radiation Oncology 2020;64(5):704-10.
  69. Bouazza YB, Chiairi I, El Kharbouchi O, De Backer L, Vanhoutte G, Janssens A, Van Meerbeeck JP. Patient-reported outcome measures (PROMs) in the management of lung cancer: a systematic review. Lung cancer 2017;113:140-51.
  70. Kim AH, Roberts C, Feagan BG, Banerjee R, Bemelman W, Bodger K, Derieppe M, Dignass A, Driscoll R, Fitzpatrick R, Gaarentstroom-Lunt J. Developing a standard set of patient-centred outcomes for inflammatory bowel disease—an international, cross-disciplinary consensus. Journal of Crohn's and Colitis 2018;12(4):408-18.
  71. Velikova G, Coens C, Efficace F, Greimel E, Groenvold M, Johnson C, Singer S, Van De Poll-Franse L, Young T, Bottomley A, EORTC Quality of Life Group. Health-related quality of life in EORTC clinical trials—30 years of progress from methodological developments to making a real impact on oncology practice. European journal of cancer supplements 2012;10(1):141-9.
  72. de Jong MJ, Roosen D, Degens JH, van den Heuvel TR, Romberg-Camps M, Hameeteman W, Bodelier AG, Romanko I, Lukas M, Winkens B, Markus T. Development and validation of a patient-reported score to screen for mucosal inflammation in inflammatory bowel disease. Journal of Crohn's and Colitis 2019;13(5):555-63.
  73. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez NJ, Filiberti A, Flechtner H, Fleishman SB, Haes JC, Kaasa S. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. JNCI: Journal of the National Cancer Institute 1993;85(5):365-76.
  74. Snyder CF, Aaronson NK. Use of patient-reported outcomes in clinical practice. The Lancet 2009;374(9687):369-70.
  75. Duncan EA, Murray J. The barriers and facilitators to routine outcome measurement by allied health professionals in practice: a systematic review. BMC health services research 2012;12:1-9.
  76. Mitchell AJ, Meader N, Symonds P. Diagnostic validity of the Hospital Anxiety and Depression Scale (HADS) in cancer and palliative settings: a meta-analysis. Journal of affective disorders 2010;126(3):335-48.
  77. Wiering B, de Boer D, Delnoij D. Patient involvement in the development of patient‐reported outcome measures: a scoping review. Health Expectations 2017;20(1):11-23.
  78. Wild D, Eremenco S, Mear I, Martin M, Houchin C, Gawlicki M, Hareendran A, Wiklund I, Chong LY, Von Maltzahn R, Cohen L. Multinational trials—recommendations on the translations required, approaches to using the same language in different countries, and the approaches to support pooling the data: the ISPOR patient-reported outcomes translation and linguistic validation good research practices task force report. Value in Health 2009;12(4):430-40.
  79. Scott N, Fayers P, Aaronson N, Bottomley A, de Graeff A, Groenvold M, Gundy C, Koller M, Petersen MA, Sprangers MA. EORTC QLQ-C30. Reference values. Brussels: EORTC, 2008.
  80. Bottomley A, Efficace F, Thomas R, Vanvoorden V, Ahmedzai SH. Health-related quality of life in non–small-cell lung cancer: methodologic issues in randomized controlled trials. Journal of Clinical Oncology. 2003;21(15):2982-92.
  81. Tan ML, Idris DB, Teo LW, Loh SY, Seow GC, Chia YY, Tin AS. Validation of EORTC QLQ-C30 and QLQ-BR23 questionnaires in the measurement of quality of life of breast cancer patients in Singapore. Asia-Pacific journal of oncology nursing 2014;1(1):22-32.
  82. Van Andel G, Bottomley A, Fosså SD, Efficace F, Coens C, Guerif S, Kynaston H, Gontero P, Thalmann G, Akdas A, D’Haese S. An international field study of the EORTC QLQ-PR25: a questionnaire for assessing the health-related quality of life of patients with prostate cancer. European journal of cancer 2008;44(16):2418-24.
  83. López-Jornet P, Camacho-Alonso F, López-Tortosa J, Tovar TP, Rodríguez-Gonzales MA. Assessing quality of life in patients with head and neck cancer in Spain by means of EORTC QLQ-C30 and QLQ-H&N35. Journal of Cranio-Maxillofacial Surgery 2012;40(7):614-20.
  84. Singer S, Wollbrück D, Wulke C, Dietz A, Klemm E, Oeken J, Meister EF, Gudziol H, Bindewald J, Schwarz R. Validation of the EORTC QLQ‐C30 and EORTC QLQ‐H&N35 in patients with laryngeal cancer after surgery. Head & Neck: Journal for the Sciences and Specialties of the Head and Neck 2009;31(1):64-76.
  85. Aaronson NK, Cull A, Kaasa S, Sprangers MA. The European Organisation for Research and Treatment of Cancer (EORTC) modular approach to quality-of-life assessment in oncology: an update. InQuality of Life and Pharmacoeconomics 1996;179-189. Raven Press.
  86. Egan M, Burke E, Meskell P, MacNeela P, Dowling M. Quality of life and resilience related to chemotherapy-induced peripheral neuropathy in patients post treatment with platinums and taxanes. Journal of Research in Nursing 2015;20(5):385-98.
  87. van der Kloot WA, Kobayashi K, Yamaoka K, Inoue K, Nortier HW, Kaptein AA. Summarizing the fifteen scales of the EORTC QLQ-C30 questionnaire by five aggregate scales with two underlying dimensions: a literature review and an empirical study. Journal of psychosocial oncology 2014;32(4):413-30.
  88. Koller M, Aaronson NK, Blazeby J, Bottomley A, Dewolf L, Fayers P, Johnson C, Ramage J, Scott N, West K, EORTC Quality of Life Group. Translation procedures for standardised quality of life questionnaires: The European Organisation for Research and Treatment of Cancer (EORTC) approach. European Journal of Cancer 2007;43(12):1810-20.
  89. Yusufov M, Adeyemi O, Flannery M, Bouillon-Minois JB, Van Allen K, Cuthel AM, Goldfeld KS, Ouchi K, Grudzen CR, EMPallA Investigators. Psychometric Properties of the Functional Assessment of Cancer Therapy-General for Evaluating Quality of Life in Patients With Life-Limiting Illness in the Emergency Department. Journal of Palliative Medicine 2024;27(1):63-74.
  90. Cella DF, Tulsky DS, Gray G, Sarafian B, Linn E, Bonomi A, Silberman M, Yellen SB, Winicour P, Brannon J, Eckberg K. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 1993;11(3):570-9.
  91. Teckle P, Peacock S, McTaggart-Cowan H, van der Hoek K, Chia S, Melosky B, Gelmon K. The ability of cancer-specific and generic preference-based instruments to discriminate across clinical and self-reported measures of cancer severities. Health and quality of life outcomes 2011;9:1-0.
  92. Cella D, Hernandez L, Bonomi AE, Corona M, Vaquero M, Shiomoto G, Baez L. Spanish language translation and initial validation of the functional assessment of cancer therapy quality-of-life instrument. Medical care 1998;36(9):1407-18.
  93. Pearman T, Yanez B, Peipert J, Wortman K, Beaumont J, Cella D. Ambulatory cancer and US general population reference values and cutoff scores for the functional assessment of cancer therapy. Cancer 2014;120(18):2902-9.
  94. Yanez B, Pearman T, Lis CG, Beaumont JL, Cella D. The FACT-G7: a rapid version of the functional assessment of cancer therapy-general (FACT-G) for monitoring symptoms and concerns in oncology practice and research. Annals of oncology 2013;24(4):1073-8.
  95. Webster K, Cella D, Yost K. The F unctional A ssessment of C hronic I llness T herapy (FACIT) Measurement System: properties, applications, and interpretation. Health and quality of life outcomes 2003;1:1-7.
  96. Sánchez R, Ballesteros M, Arnold BJ. Validation of the FACT-G scale for evaluating quality of life in cancer patients in Colombia. Quality of life Research 2011;20:19-29.
  97. Webster K, Cella D, Yost K. The Functional Assessment of Chronic Illness Therapy (FACIT) Measurement System: properties, applications, and interpretation. Health and quality of life outcomes 2003;1:1-7.
  98. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta psychiatrica scandinavica 1983;67(6):361-70.
  99. Herrmann C. International experiences with the Hospital Anxiety and Depression Scale-a review of validation data and clinical results. Journal of psychosomatic research 1997;42(1):17-41.
  100. Lawrie I, Lloyd-Williams M, Taylor F. How do palliative medicine physicians assess and manage depression. Palliative Medicine 2004;18(3):234-8.
  101. Hansson M, Chotai J, Nordstöm A, Bodlund O. Comparison of two self-rating scales to detect depression: HADS and PHQ-9. British Journal of General Practice 2009;59(566):e283-8.
  102. Snaith RP. The hospital anxiety and depression scale. Health and quality of life outcomes 2003;1:1-4.
  103. Ware Jr JE. SF-36 health survey update. Spine 2000;25(24):3130-9.
  104. Bunevicius A. Reliability and validity of the SF-36 Health Survey Questionnaire in patients with brain tumors: a cross-sectional study. Health and quality of life outcomes 2017;15:1-7.
  105. Contopoulos-Ioannidis DG, Karvouni A, Kouri I, Ioannidis JP. Reporting and interpretation of SF-36 outcomes in randomised trials: systematic review. British medical journal 2009;12;338.
  106. Fredheim OM, Borchgrevink PC, Saltnes T, Kaasa S. Validation and comparison of the health-related quality-of-life instruments EORTC QLQ-C30 and SF-36 in assessment of patients with chronic nonmalignant pain. Journal of Pain and Symptom Management 2007;34(6):657-65.
  107. Patel AA, Donegan D, Albert T. The 36-item short form. JAAOS-Journal of the American Academy of Orthopaedic Surgeons 2007;1;15(2):126-34.
  108. van der Meulen M, Zamanipoor Najafabadi AH, Lobatto DJ, Andela CD, Vliet Vlieland TP, Pereira AM, van Furth WR, Biermasz NR. SF-12 or SF-36 in pituitary disease? Toward concise and comprehensive patient-reported outcomes measurements. Endocrine 2020;70(1):123-33.
  109. Jenkinson C, Layte R. Development and testing of the UK SF-12. Journal of health services research & policy 1997;2(1):14-8.
  110. Ģiga L, Pētersone A, Čakstiņa S, Bērziņa G. Comparison of content and psychometric properties for assessment tools used for brain tumor patients: a scoping review. Health and Quality of Life Outcomes 2021;19:1-8.
  111. Davda J, Kibet H, Achieng E, Atundo L, Komen T. Assessing the acceptability, reliability, and validity of the EORTC Quality of Life Questionnaire (QLQ-C30) in Kenyan cancer patients: a cross-sectional study. Journal of Patient-Reported Outcomes 2021;5:1-8.
  112. Weitzner MA, Meyers CA, Gelke CK, Byrne KS, Levin VA, Cella DF. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT‐G) in patients with primary brain tumors. Cancer 1995;1;75(5):1151-61.
  113. Lee CT, Lin CY, Tsai MC, Strong C, Lin YC. Psychometric evaluation and wording effects on the Chinese version of the parent-proxy Kid-KINDL. Health and Quality of Life Outcomes 2016;14:1-0.
  114. King MT, Bell ML, Costa D, Butow P, Oh B. The Quality of Life Questionnaire Core 30 (QLQ-C30) and Functional Assessment of Cancer-General (FACT-G) differ in responsiveness, relative efficiency, and therefore required sample size. Journal of clinical epidemiology 2014;1;67(1):100-7.
  115. Iravani K, Jafari P, Akhlaghi A, Khademi B. Assessing whether EORTC QLQ-30 and FACT-G measure the same constructs of quality of life in patients with total laryngectomy. Health and quality of life outcomes 2018;16:1-8.
  116. Erez G, Selman L, Murtagh FE. Measuring health-related quality of life in patients with conservatively managed stage 5 chronic kidney disease: limitations of the Medical Outcomes Study Short Form 36: SF-36. Quality of Life Research 2016;25:2799-809.
  117. Narra LR, Verdini N, Lapen K, Nipp R, Gillespie EF. Patient-Reported Outcomes in Clinical Trials: From an Endpoint to an Intervention in Cancer Care. In Seminars in Radiation Oncology WB Saunders 2023;33(4):358-366 p.
  118. Aiyegbusi OL, Nair D, Peipert JD, Schick-Makaroff K, Mucsi I. A narrative review of current evidence supporting the implementation of electronic patient-reported outcome measures in the management of chronic diseases. Therapeutic advances in chronic disease 2021;12:20406223211015958.
  119. Sathe M, Moshiree B, Vu PT, Khan U, Heltshe SL, Romasco M, Freedman SD, Schwarzenberg SJ, Goss CH, Freeman AJ. Utilization of electronic patient-reported outcome measures in cystic fibrosis research: application to the GALAXY study. Journal of Cystic Fibrosis 2021;20(4):605-11.
  120. Basch E, Deal AM, Kris MG, Scher HI, Hudis CA, Sabbatini P, Rogak L, Bennett AV, Dueck AC, Atkinson TM, Chou JF. Symptom monitoring with patient-reported outcomes during routine cancer treatment: a randomized controlled trial. Journal of Clinical Oncology 2016;34(6):557.
  121. Sandler KA, Mitchell SA, Basch E, Raldow AC, Steinberg ML, Sharif J, Cook RR, Kupelian PA, McCloskey SA. Content validity of anatomic site-specific patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE) item sets for assessment of acute symptomatic toxicities in radiation oncology. International Journal of Radiation Oncology* Biology* Physics 2018;102(1):44-52.
  122. García Abejas A, Serra Trullás A, Sobral MA, Canelas D, Leite Costa F, Salvador Verges À. Improving the Understanding and Managing of the Quality of Life of Patients With Lung Cancer With Electronic Patient-Reported Outcome Measures: Scoping Review. Journal of Medical Internet Research 2023;25:e46259.
  123. Kitaura K, Hashimoto T, Wada Y, Sasaki Y, Shirakata S, Oga K, Oka T, Nakamura A, Nakaji S. A case of endocardial resection for the treatment of ventricular arrhythmia with left ventricular aneurysm. Kyobu geka. The Japanese Journal of Thoracic Surgery 1986;39(2):122-7.
  124. Van Den Hurk CJ, Mols F, Eicher M, Chan RJ, Becker A, Geleijnse G, Walraven I, Coolbrandt A, Lustberg M, Velikova G, Charalambous A. A narrative review on the collection and use of electronic patient-reported outcomes in cancer survivorship care with emphasis on symptom monitoring. Current Oncology 2022;17;29(6):4370-85.
  125. Longley D. KEEPROM. In computer security, an EPROM whose contents cannot be read unless a specific data value is given to it. See EEPROM. Kennedy. In computer security, a virus.London 1992;274-287.
  126. McCleary NJ, Wigler D, Berry D, Sato K, Abrams T, Chan J, Enzinger P, Ng K, Wolpin B, Schrag D, Fuchs CS. Feasibility of computer‐based self‐administered cancer‐specific geriatric assessment in older patients with gastrointestinal malignancy. The oncologist 2013;18(1):64-72.
  127. Richter JG, Becker A, Koch T, Nixdorf M, Willers R, Monser R, Schacher B, Alten R, Specker C, Schneider M. Self-assessments of patients via Tablet PC in routine patient care: comparison with standardised paper questionnaires. Annals of the rheumatic diseases 2008;67(12):1739-41.
  128. Meirte J, Hellemans N, Anthonissen M, Denteneer L, Maertens K, Moortgat P, Van Daele U. Benefits and disadvantages of electronic patient-reported outcome measures: systematic review. Journal of Medical Internet Research perioperative medicine 2020;3(1):e15588.
  129. Wald T, Zebralla V, Boege M, Kunz V, Neumuth T, Dietz A, Wichmann G, Wiegand S. Web-Based Patient-Reported Outcomes for ENT Patients—Evaluation of the Status Quo, Patients’ View, and Future Perspectives. International Journal of Environmental Research and Public Health 2022;19(18):11773.
  130. Ngamkham S, Vincent C, Finnegan L, Holden JE, Wang ZJ, Wilkie DJ. The McGill Pain Questionnaire as a multidimensional measure in people with cancer: an integrative review. Pain Management Nursin 2012;1;13(1):27-51.
  131. Graham C, Bond SS, Gerkovich MM, Cook MR. Use of the McGill Pain Questionnaire in the assessment of cancer pain: replicability and consistency. Pain 1980;8(3):377–387.
  132. Wilkie DJ, Judge MK, Berry DL, Dell J, Zong S, Gilespie R. Usability of a computerized PAINReportIt in the general public with pain and people with cancer pain. Journal of pain and symptom management 2003;1;25(3):213-24.
  133. Cook AJ, Roberts DA, Henderson MD, Van Winkle LC, Chastain DC, Hamill-Ruth RJ. Electronic pain questionnaires: a randomized, crossover comparison with paper questionnaires for chronic pain assessment. Pain 2004;1;110(1-2):310-7.
  134. McCleary NJ, Haakenstad EK, Cleveland JL, Manni M, Hassett MJ, Schrag D. Framework for integrating electronic patient-reported data in routine cancer care: an Oncology Intake Questionnaire. JAMIA open 2022;1;5(3):ooac064.
Statistics
Article View: 480
PDF Download: 276


Journal Management System. Powered by iJournalPro.com